Davenport Andrew
UCL Centre for Nephrology, Royal Free & University College Medical School, London, United Kingdom.
Perit Dial Int. 2009 May-Jun;29(3):297-302.
Over the past two decades, the rate of peritonitis in patients treated by peritoneal dialysis (PD) has been significantly reduced. However, peritonitis remains a major complication of PD, accounting for considerable mortality and hospitalization among PD patients.
To compare the outcome of peritonitis in a large unselected group of PD patients with that from single-center and selected groups.
We audited the outcome of peritonitis in PD patients attending the 12 PD units in the Thames area in 2002 and 2003. There were 538 patients on continuous ambulatory PD (CAPD) and 325 patients on automated PD (APD) and/or continuous cycling PD (CCPD) at the end of 2002, and 635 CAPD and 445 APD/CCPD patients at the end of 2003.
There were 1467 episodes of PD peritonitis during the 2-year period, including 129 recurrent episodes, with the average number of months between peritonitis episodes being 14.7 for CAPD and 18.1 for APD/CCPD, p < 0.05. However there was considerable variation between units. Coagulase-negative staphylococcus (CoNS) was the most common cause, accounting for around 30% of all peritonitis episodes, including recurrences, followed by non-pseudomonas gram negatives and Staphylococcus aureus. Cure rates were 77.2% for CoNS, 46.6% for S. aureus, and 7.7% for methicillin-resistant S. aureus. The cure rate for pseudomonas was 21.4%, and other gram negatives 56.7%. In total, there were 351 episodes of culture-negative peritonitis, with an average cure rate of 76.9%. Cure rates were higher for those centers that used a combination of intraperitoneal gentamicin and cephalosporins than those centers that used oral-based regimes. A total of 296 PD catheters were removed as a direct consequence of PD peritonitis: 121 due to gram-positive and 123 due to gram-negative organisms. Only 49 catheters were reinserted and the patients returned to PD. 52 patients died during or subsequent to their episode of PD peritonitis, with an overall mortality rate of 3.5%.
This audit showed that, in a large unselected population of PD patients, the incidence of peritonitis was significantly greater than that reported in single-center short-term studies, and varied from unit to unit. Similarly, the success of treating PD peritonitis varied not only with the cause of the infection but also from unit to unit. PD peritonitis remains a major cause of patients discontinuing PD and switching to hemodialysis.
在过去二十年中,接受腹膜透析(PD)治疗的患者腹膜炎发生率已显著降低。然而,腹膜炎仍是PD的主要并发症,在PD患者中导致相当高的死亡率和住院率。
比较一大组未经挑选的PD患者与单中心及经过挑选的患者组的腹膜炎治疗结果。
我们审核了2002年和2003年在泰晤士地区12个PD治疗单元接受治疗的PD患者的腹膜炎治疗结果。2002年末有538例持续非卧床腹膜透析(CAPD)患者和325例自动化腹膜透析(APD)和/或持续循环腹膜透析(CCPD)患者,2003年末有635例CAPD患者和445例APD/CCPD患者。
在这2年期间共发生1467次PD腹膜炎发作,包括129次复发发作,CAPD患者腹膜炎发作间隔的平均月数为14.7个月,APD/CCPD患者为18.1个月,p<0.05。然而各治疗单元之间存在相当大的差异。凝固酶阴性葡萄球菌(CoNS)是最常见的病因,占所有腹膜炎发作(包括复发)的约30%,其次是非假单胞菌革兰阴性菌和金黄色葡萄球菌。CoNS的治愈率为77.2%,金黄色葡萄球菌为46.6%,耐甲氧西林金黄色葡萄球菌为7.7%。假单胞菌的治愈率为21.4%,其他革兰阴性菌为56.7%。共有351次培养阴性腹膜炎发作,平均治愈率为76.9%。使用腹腔内庆大霉素和头孢菌素联合治疗的中心的治愈率高于使用口服治疗方案的中心。共有296根PD导管因PD腹膜炎而直接拔除:121根因革兰阳性菌,123根因革兰阴性菌。仅49根导管重新插入,患者恢复PD治疗。52例患者在PD腹膜炎发作期间或之后死亡,总死亡率为3.5%。
本次审核表明,在一大组未经挑选的PD患者中,腹膜炎发生率显著高于单中心短期研究报告的发生率,且各治疗单元之间存在差异。同样,PD腹膜炎的治疗成功率不仅因感染病因不同而异,各治疗单元之间也存在差异。PD腹膜炎仍然是患者停止PD治疗并转为血液透析的主要原因。